Heparin Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Nov 14, 2017.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-7620-03
- Dosage Form
- Injection
- Presentation
- Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)
- Initial Posting
- Nov 14, 2017